Amphastar Pharmaceuticals, Inc.AMPHNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank86
3Y CAGR+9.3%
5Y CAGR+66.6%
Year-over-Year Change
Profit from core business operations before interest and taxes
3Y CAGR
+9.3%/yr
Annual compound
5Y CAGR
+66.6%/yr
Recent deceleration
Percentile
P86
Within normal range
vs 5Y Ago
12.8x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $140.40M | -31.7% |
| 2024 | $205.42M | +4.3% |
| 2023 | $196.99M | +83.2% |
| 2022 | $107.50M | +53.8% |
| 2021 | $69.89M | +538.0% |
| 2020 | $10.95M | +28187.2% |
| 2019 | $-39000.00 | +99.5% |
| 2018 | $-8.62M | -863.5% |
| 2017 | $-895000.00 | -105.7% |
| 2016 | $15.69M | - |